文献速递甲状腺疾病

患者对检测和治疗的要求影响医生对甲减的管理

Patient Requests for Tests and Treatments Impact Physician Management of Hypothyroidism.
PubMed 文献 · Thyroid · 2019-10-10

该研究随机调查了内分泌学会、美国家庭医师学会和美国老年医学会的医生,评估甲状腺激素治疗管理的障碍。63%的应答率中,46%的医生认为患者对检测和治疗的要求是适当管理的障碍,内分泌医生和甲状腺激素患者比例高的医生更可能报告此障碍,执业年限长的医生则较少。

要点

  • 46%的医生认为患者对检测和治疗的要求是甲减管理的障碍。
  • 内分泌医生和甲状腺激素患者比例高的医生更可能报告患者要求为障碍。
  • 部分医生会遵从患者非常规要求,可能导致不当治疗。

核心结论

  • 医生报告患者对检测和治疗的要求是甲状腺激素适当管理的常见障碍。
  • 在某些情况下,医生遵从患者要求可能是不适当治疗的驱动因素并导致伤害。

研究设计与样本

  • 随机调查内分泌学会、美国家庭医师学会和美国老年医学会的医生成员。
  • 应答率为63%(359/566)。
  • 采用多变量逻辑回归分析确定与医生报告最常见障碍(包括患者要求)相关的因素。

主要发现

  • 46%的医生报告患者对检测和治疗的要求有点到非常可能是甲状腺激素适当管理的障碍。
  • 内分泌医生相比初级保健医生报告患者要求为障碍的OR=2.29(95%CI 1.03-5.23)。
  • 每年甲状腺激素治疗患者超过25%的医生相比少于25%的医生OR=1.90(95%CI 1.05-3.46)。
  • 执业11-20年的医生相比≤10年的医生OR=0.44(95%CI 0.21-0.89),>20年的医生OR=0.24(95%CI 0.12-0.46)。
  • 医生报告的患者要求包括:要求非合成甲状腺素制剂(52%)、在生化正常时根据症状调整剂量(52%)、维持TSH低于参考范围(32%)、根据血清T3水平调整剂量(21%)。

关键数值与推荐

  • 医生报告收到患者对前三种非常规实践的要求时更可能执行(分别为p<0.001,p=0.014,p<0.001)。

临床怎么用

  • 临床医生应认识到患者要求可能影响甲减管理决策,需平衡患者需求与循证实践。
  • 了解医生报告的障碍及相关因素有助于改善患者护理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Levothyroxine is one of the most commonly prescribed medications in the United States. Although prior research focused on over- and undertreatment and patient dissatisfaction with thyroid hormone, little is known about physician-reported barriers to managing thyroid hormone therapy. In addition, the impact of patient requests for tests and treatments on hypothyroidism management remains unexplored. Methods: We randomly surveyed physician members of the Endocrine Society, American Academy of Family Practice and American Geriatrics Society. Respondents were asked to rate barriers to management of thyroid hormone therapy. We conducted multivariable logistic regression analyses to determine correlates with physician report of the most commonly reported barriers, including patient requests. Results: Response rate was 63% (359/566). Almost half of the physicians reported that patient requests for tests and treatments were somewhat to very likely to being a barrier to appropriate management of thyroid hormone therapy (46%). Endocrinologists (odds ratio [OR] = 2.29 [95% confidence interval, CI 1.03-5.23], compared with primary care physicians) and physicians with more than 25% of patients on thyroid hormone therapy per year (OR = 1.90 [CI 1.05-3.46], compared with those with <25% patients per year) were more likely to report patient requests as a barrier. Physicians with more years in practice were less likely to do so (11-20 years: OR = 0.44 [CI 0.21-0.89]; >20 years: OR = 0.24 [CI 0.12-0.46], compared with ≤10 years). Physician-reported patient requests included requests for preparations other than synthetic thyroxine (52%), adjusting thyroid hormone dose based on symptoms when biochemically euthyroid (52%), maintaining thyrotropin level below the reference range (32%), and adjusting dose according to serum T3 level (21%). Physicians who reported receiving patient requests for the former three unconventional practices were more likely to execute them (p < 0.001, p = 0.014, p < 0.001, respectively). Conclusions: Physicians reported patient requests for tests and treatments as a common barrier to appropriate thyroid hormone management. In some scenarios, physician adherence to patient requests may be a driver for inappropriate care and lead to harm. Understanding physician-reported barriers to thyroid hormone management and factors associated with physician perception that patient requests are a barrier is key to improving patient care.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Esfandiari NH, Reyes-Gastelum D, Hawley ST, et al. Patient Requests for Tests and Treatments Impact Physician Management of Hypothyroidism. Thyroid. 2019. PMID: 31436135. doi:10.1089/thy.2019.0383

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。